BiotechTube
Home/AvenCell Therapeutics/Reynald Lescarbeau, Ph.D.
RL

Reynald Lescarbeau, Ph.D.

SVP, Global Research

AvenCell Therapeutics

Therapeutic Areas

Oncology

AvenCell Therapeutics Pipeline

DrugIndicationPhase
Universal Switchable CAR-T ProgramsHard-to-treat cancers (hematological and solid tumors)Phase 1

Leadership Team at AvenCell Therapeutics

AS
Andrew Schiermeier, Ph.D.
Chief Executive Officer
MK
Manfred Klevesath, MD, Ph.D.
Chief Medical Officer
MC
Marc Cartellieri, Ph.D.
Chief Technology Officer
SB
Susan Buttler
VP, Clinical Operations
View full AvenCell Therapeutics profile